ref_name,original_continent_name,status,annotation,action
Abecasis07,NULL,EX,<25 RTs (1 RTs),NULL
Abongwa19,NULL,JIntAIDSSoc2020,,NULL
Acharya19,NULL,EX,<25 PTs,NULL
Adojaan05,NULL,EX,<25 RTs (4 RTs),NULL
Aghokeng09,NULL,PLOSMED2015,WHO HIVDR-TS Survey,NULL
Aghokeng11,NULL,PLOSMED2015,,NULL
Agwale06,NULL,EX,<25 RTs (18 RTs),NULL
Ajoge12,NULL,PLOSMED2015,,NULL
Akrim12,NULL,EX,Excluded (Rx not described),NULL
Alaoui18,NULL,EX,<25 RTs,NULL
Albert94,NULL,EX,<25 RTs (23 RTs),NULL
Alencar13,NULL,PLOSMED2015,6 pts ARV-exposed were removed from DB,NULL
Alexiev15,NULL,EX,Previous ART exposed included; PMTCT (1.6%) included,NULL
Alizon86,NULL,EX,<25 RTs (2 RTs),NULL
Amogne16,NULL,EX,<25 RTs (CPR QA),NULL
An12,NULL,PLOSMED2015,CRF01_AE clusters in MSMs living in Liaoning; two with M46I and one with L90M; The two with M46I are closed related phylogenetically;,NULL
Anderson00,NULL,EX,<25 RTs (4 RTs),NULL
Andersson99,NULL,EX,<25 RTs (7 RTs),NULL
Andresen07,NULL,EX,<25 RTs (17 RTs),NULL
Annaz11,NULL,PLOSMED2015,"Arabic, North Africa",NULL
Antoniadou13,NULL,PLOSMED2015,Several transmission clusters,NULL
Apetrei98,NULL,EX,<25 RTs (14 RTs),NULL
Araújo19,NULL,JIntAIDSSoc2020,,NULL
Arien05,NULL,EX,<25 RTs (23 RTs),NULL
Ariffin14,NULL,JIntAIDSSoc2020,,NULL
Arimide18,NULL,JIntAIDSSoc2020,,NULL
Arora08,NULL,EX,Seq Leng: 75-229 ,NULL
Arroyo04,NULL,EX,<25 RTs (20 RTs),NULL
Arroyo05,NULL,EX,<25 RTs (14 RTs),NULL
Arruda10,NULL,EX,<25 RTs,NULL
Arruda10b,NULL,PLOSMED2015,,NULL
Arruda18,NULL,JIntAIDSSoc2020,,NULL
Aulicino05,NULL,EX,<25 RTs (1 RTs),NULL
Aulicino05b,NULL,EX,<25 RTs (1 RTs),NULL
Aulicino19,NULL,EX,Pediatric,NULL
Auwanit09,NULL,EX,Cloned,NULL
Avi09,NULL,PLOSMED2015,A Former Soviet Union;  Mainly CRF06_cpx,NULL
Avi10,NULL,EX,<25 RTs,NULL
Avi10b,NULL,PLOSMED2015,A Former Soviet Union; Mainly CRF06_cpx.,NULL
Avi13,NULL,PLOSMED2015,,NULL
Avila-Rios12,NULL,PLOSMED2015,,NULL
Ay17,NULL,JIntAIDSSoc2020,,NULL
Ay20,NULL,New,,NULL
Ayouba09,Africa,PLOSMED2015,"WHO HIVDR-TS Survey; Overall TDR is 0.8% (266); 0% in Africa, 1.7% in Asia.",NULL
Ayouba09,Asia,PLOSMED2015,"WHO HIVDR-TS Survey; Overall TDR is 0.8% (266); 0% in Africa, 1.7% in Asia.",NULL
Babic06,NULL,PLOSMED2015,,NULL
Badreddine07,NULL,EX,<25 RTs,NULL
Baker07,NULL,PLOSMED2015,Emailed to Author; Big discrepancy of SDRM between what has been described  (0% in the paper) and what has been submitted to GB (only 68 samples in the paper).,NULL
Balakrishnan05,NULL,PLOSMED2015,Positions containing mutations rather than mutations themselves were studied.,NULL
Baldrich-Rubio01,NULL,EX,<25 RTs (1 RTs),NULL
Balode10,NULL,PLOSMED2015,A Former Soviet Union; SPREAD study,NULL
Balotta00,NULL,PLOSMED2015,,NULL
Bang08,NULL,PLOSMED2015,,NULL
Bao08,NULL,PLOSMED2015,Isolates from sexually infected 46 ARV-naives were sequenced.,NULL
Bao14,NULL,JIntAIDSSoc2020,,NULL
Barreto06,NULL,EX,Seq Leng: 1-208 ,NULL
Barrow13,NULL,EX,Previous ART exposed included; PMTCT included; Direct Submission to HIVDB,NULL
Bartolo09,NULL,PLOSMED2015,TDR study,NULL
Bartolo11,NULL,EX,<25 RTs (3 RTs),NULL
Bartolo14,NULL,PLOSMED2015,,NULL
Baudi17,NULL,JIntAIDSSoc2020,,NULL
Baxter21,NULL,New,,NULL
Becker-Pergola00,NULL,PLOSMED2015,Study of subtype and polymorphism.,NULL
Bellocchi05,NULL,PLOSMED2015,The paper states that two samples were from a same patient so one sample was removed.,NULL
Bernardin05,NULL,EX,<25 RTs (18 RTs),NULL
Bessong05,NULL,EX,<25 RTs (13 RTs),NULL
Bessong06,NULL,PLOSMED2015,,NULL
Bessong13,NULL,EX,<25 RTs,NULL
Bila13,NULL,PLOSMED2015,"Four surveys (two sites, two different years)",NULL
Billings16,NULL,JIntAIDSSoc2020,,NULL
Billings17,NULL,JIntAIDSSoc2020,,NULL
Billings19,NULL,JIntAIDSSoc2020,Repondent-driven sampling; A half of participants with VL of >1000 were sequenced,NULL
Billong13,NULL,PLOSMED2015,139 baseline and 7 follow-up sequences,NULL
Boender15,NULL,New,,NULL
Boerma16,NULL,EX,Pediatric,NULL
Bontell11,NULL,PLOSMED2015,,NULL
Bonura10,NULL,PLOSMED2015,,NULL
Bouchard07,NULL,EX,<25 RTs (20 RTs),NULL
Bracho14,NULL,JIntAIDSSoc2020,,Include_Rx_Unknown
Bradley-Stewart17,NULL,EX,<25 RTs,NULL
Brado18,NULL,EX,<25 RTs,NULL
Brennan07,NULL,EX,<25 RTs,NULL
Brennan08,NULL,EX,<25 RTs,NULL
Brennan09,NULL,PLOSMED2015,The paper did not count T215Revertants.,NULL
Brennan10,NULL,PLOSMED2015,,NULL
Brigido07,NULL,PLOSMED2015,Study of subtype C and CB ,NULL
Brindeiro03,NULL,PLOSMED2015,TDR study (HIV-BResNet); 357 Accessions in GB but only 198 Accessions include RT;,NULL
Brindeiro99,NULL,EX,<25 RTs (18 RTs),NULL
Brockman12,NULL,EX,<25 RTs,NULL
Brooks13,NULL,PLOSMED2015,155 were submitted to GB with additional 119 from ARV-naïves used as backgound in the tree analysis.,NULL
Brown00,NULL,PLOSMED2015,"Study of TDR by susceptibility; Sampling from 1989 to 1998; however, the paper says that 85% were since 1996.",NULL
Brown04,NULL,EX,<25 RTs,NULL
Brown05,NULL,EX,<25 RTs (21 RTs),NULL
Brown09,NULL,PLOSMED2015,,NULL
Brumme07,NULL,PLOSMED2015,Study of HLA and CTL,NULL
Brumme09,NULL,PLOSMED2015,"Study of HLA and Epitopes; Combined study of 765 from HOMER, 230 from WAHCS, and 555 from ACTG5128; 230 WAHCS not entered because of sequence QA;",NULL
Bruzzone15,NULL,JIntAIDSSoc2020,,NULL
Budambula15,NULL,EX,<25 RTs,NULL
Bussmann05,NULL,PLOSMED2015,,NULL
Bussmann11,NULL,PLOSMED2015,WHO HIVDR-TS Survey,NULL
Capel13,NULL,EX,<25 RTs,NULL
Caplinskas13,NULL,JIntAIDSSoc2020,Sequences available since 2013,NULL
Capoferri20,NULL,New,,NULL
Cardoso09,NULL,PLOSMED2015,,NULL
Caron08,NULL,EX,<25 RTs (19 RTs),NULL
Caron12,NULL,PLOSMED2015,Sequences from 107 patients included but RT is available only for 97,NULL
Carr01,NULL,EX,<25 RTs (7 RTs),NULL
Carr01b,NULL,EX,<25 RTs (21 RTs),NULL
Carr05,Africa,PLOSMED2015,Study of subtypes comparing subtype A sequences from Uzbekistan (a former Soviet Union) with Cameroon subtype A sequences.,NULL
Carr05,Asia,PLOSMED2015,Study of subtypes comparing subtype A sequences from Uzbekistan (a former Soviet Union) with Cameroon subtype A sequences.,NULL
Carr05b,NULL,EX,<25 RTs (23 RTs),NULL
Carr06,NULL,EX,<25 RTs (2 RTs),NULL
Carr10,NULL,EX,<25 RTs (23 RTs),NULL
Carr96,NULL,EX,<25 RTs (1 RTs),NULL
Carr98,NULL,EX,<25 RTs (4 RTs),NULL
Carrion03,NULL,EX,<25 RTs (2 RTs),NULL
Carrion04,NULL,EX,<25 RTs (2 RTs),NULL
Carvalho11,NULL,PLOSMED2015,,NULL
Carvalho15,NULL,JIntAIDSSoc2020,,NULL
Casado03,NULL,EX,<25 RTs (1 RTs),NULL
Casado05,NULL,EX,<25 RTs (2 RTs),NULL
Castelbranco10,NULL,PLOSMED2015,Previously presented in 18th HIVDR workshop as WHO HIVDR-TS study,NULL
Castillo09,NULL,PLOSMED2015,"For TDR estimation, this study used 62/65 which were sequenced both PR and RT (did not analyze the 3 sequences missing PR).",NULL
Castley16,NULL,EX,Cloned,NULL
Castro10,NULL,PLOSMED2015,,NULL
Caumont01,NULL,EX,<25 RTs (2 RTs),NULL
Chaillon17,NULL,JIntAIDSSoc2020,,NULL
Chaix03,NULL,PLOSMED2015,,NULL
Chamberland12,NULL,PLOSMED2015,,NULL
Chang08,NULL,PLOSMED2015,,NULL
Chang18,NULL,JIntAIDSSoc2020,,NULL
Chang20,NULL,New,,NULL
Charpentier11,NULL,PLOSMED2015,"Sequences containing F77L, K219R, V75A, or K219N were not counted.",NULL
Charurat12,NULL,EX,<25 Pts,NULL
Chaturbhuj10,NULL,PLOSMED2015,,NULL
Chehadeh15,NULL,JIntAIDSSoc2020,,NULL
Chehadeh17,NULL,EX,<25 RTs,NULL
Chen12,NULL,PLOSMED2015,,NULL
Chen13,NULL,PLOSMED2015,the paper is in Chinese,NULL
Chen14,NULL,JIntAIDSSoc2020,,NULL
Chen14b,NULL,JIntAIDSSoc2020,,NULL
Chen16,NULL,JIntAIDSSoc2020,,NULL
Chen17,NULL,EX,<25 RTs,NULL
Chen17b,NULL,JIntAIDSSoc2020,,NULL
Chen18,NULL,JIntAIDSSoc2020,,NULL
Chen18b,NULL,JIntAIDSSoc2020,,NULL
Chen18c,NULL,New,,NULL
Chen19,NULL,EX,<25 PTs,NULL
Chen20,NULL,New,,NULL
Cheng20,NULL,EX,<25 PTs,NULL
Cheong14,NULL,EX,<25 Pts,NULL
Cheong15,NULL,EX,<25 Pts,NULL
Cheriro15,NULL,EX,NGS,NULL
Chibo11,NULL,PLOSMED2015,Study of transmission clusters.,NULL
Chikata14,NULL,EX,Population not described,NULL
Chin06,NULL,PLOSMED2015,HIVdb resistance scores were reported.,NULL
Chin10,NULL,PLOSMED2015,,NULL
Chin15,NULL,JIntAIDSSoc2020,,NULL
Choi08,NULL,PLOSMED2015,,NULL
Choi97,NULL,EX,<25 Pts,NULL
Chow12,NULL,EX,<25 RTs (3 RTs),NULL
Chow14,NULL,EX,<25 Pts,NULL
Chow16,NULL,JIntAIDSSoc2020,,NULL
Chung14,NULL,EX,Biased samples; BL sequences from ART failures; NGS,NULL
Church07,NULL,PLOSMED2015,Baseline sequences from Clinical trials HIVNET 012 and NVAZ (sdNVP in PMTCT); Study of the prevalence of K103N in baseline samples. ,NULL
Ciccozzi05,NULL,EX,Excluded Previously (SampleYear),NULL
Courtney16,NULL,JIntAIDSSoc2020,,NULL
Couto-Fernandez06,NULL,EX,<25 Pts,NULL
Crispim19,NULL,JIntAIDSSoc2020,,NULL
Cuevas09,NULL,PLOSMED2015,,NULL
Cuevas09b,NULL,EX,Seq Length: 1-214 ,NULL
Cuevas15,NULL,EX,<25 Pts,NULL
Dalai09,NULL,PLOSMED2015,Study of subtype C evolution,NULL
Darcissac16,NULL,JIntAIDSSoc2020,,NULL
Dauwe15,NULL,JIntAIDSSoc2020,,NULL
DeGascun12,NULL,PLOSMED2015,,NULL
Dean11,NULL,PLOSMED2015,,NULL
Deho08,NULL,PLOSMED2015,,NULL
Delatorre16,NULL,EX,<25 Pts,NULL
Delatorre17,NULL,JIntAIDSSoc2020,,NULL
Delgado08,NULL,EX,Rx Na•ve was not an inclusion criteria. Some were treated.,NULL
Delgado15,NULL,JIntAIDSSoc2020,,NULL
Delwart12,NULL,PLOSMED2015,,NULL
Derache07,NULL,PLOSMED2015,,NULL
Derache08,NULL,PLOSMED2015,,NULL
Derache18,NULL,JIntAIDSSoc2020,NGS,NULL
Descamps10,NULL,PLOSMED2015,The list of 466 GBs received from Diane Descamps; Contacted: diane descamps <diane.descamps@bch.aphp.fr>; There is no direct link between GB and a paper; 573 in GB but only 466 in the paper; GB contains only RT but the paper describes both PR and RT; Is this a correct paper?,NULL
Deshpande04,NULL,PLOSMED2015,,NULL
Deshpande11,NULL,PLOSMED2015,,NULL
Dilernia07,NULL,PLOSMED2015,Study of Subtypes,NULL
Diop-Ndiaye10,NULL,PLOSMED2015,This study includes 38 from Vergne00 (Ref853).,NULL
Djoko10,NULL,PLOSMED2015,,NULL
Djoko10b,NULL,PLOSMED2015,,NULL
Dow17,NULL,EX,Pediatric,NULL
Dowling02,NULL,PLOSMED2015,Study of recombinants,NULL
Duc12,NULL,PLOSMED2015,Direct Genbank Submission; CDC study,NULL
Dumans02,NULL,PLOSMED2015,,NULL
Duque02,NULL,PLOSMED2015,Direct Genbank submission,NULL
Edoul20,NULL,New,,NULL
El-Badry20,NULL,EX,<25 PTs,NULL
Ellenberger99,NULL,EX,<25 RTs (0 RTs),NULL
Escoto-Delgadillo05,NULL,PLOSMED2015,Latin America,NULL
Escoto-Delgadillo16,NULL,JIntAIDSSoc2020,,NULL
Eshleman04,NULL,EX,Previously excluded; Not a representative study,NULL
Eshleman05,NULL,EX,<25 Pts,NULL
Eshleman07,NULL,PLOSMED2015,Most samples were from 2001 and 2002.,NULL
Eshleman09,NULL,EX,<25 RTs,NULL
Eshleman09b,NULL,PLOSMED2015,,NULL
Espinosa04,NULL,EX,<25 RTs (21 RTs),NULL
Eyzaguirre07,NULL,PLOSMED2015,"A Former Soviet Union, Central Asia; Study of subtypes",NULL
Fabeni20,NULL,New,,NULL
Fang04,NULL,EX,<25 RTs (7 RTs),NULL
Fayssel16,NULL,JIntAIDSSoc2020,,NULL
Feng14,NULL,EX,<25 Pts,NULL
Feng16,NULL,EX,<25 Pts,NULL
Feng16b,NULL,JIntAIDSSoc2020,,NULL
Feng18,NULL,EX,<25 Pts,NULL
Fernandez-Garcia12,NULL,EX,<25 RTs (10 RTs),NULL
Ferreira08,NULL,PLOSMED2015,The 89 AccessionIDs in GB contains only 49 RT. ,NULL
Ferreira11,NULL,PLOSMED2015,,NULL
Ferreira13,NULL,PLOSMED2015,4 pts with MTCT were removed from DB ,NULL
Fish10,NULL,EX,<25 RTs,NULL
Florea11,NULL,PLOSMED2015,Contacted: Otelea (dotelea@mateibals.ro),NULL
Fokam16,NULL,EX,Previous ART exposed included; ART reinitiators (8%) included,NULL
Fokam20,NULL,New,,NULL
Fonjungo02,NULL,EX,<25 RTs (0 RTs),NULL
Foster14,NULL,EX,<25 Pts,NULL
Frange12,NULL,PLOSMED2015,,NULL
Frentz13,NULL,PLOSMED2015,Spread II (the analysis in the paper used 1630 + previous Spread study),NULL
Fujisaki09,NULL,PLOSMED2015,About 400 were included from to Ibe08; Study of subtypes,NULL
Gafarova10,NULL,EX,<25 RTs,NULL
Galkin06,NULL,EX,<25 RTs (1 RTs),NULL
Galkin06b,NULL,EX,<25 RTs (4 RTs),NULL
Galluzzo07,NULL,PLOSMED2015,,NULL
Gao01,NULL,EX,<25 RTs (1 RTs),NULL
Gao96,NULL,EX,<25 RTs (3 RTs),NULL
Gao96b,NULL,EX,<25 RTs (1 RTs),NULL
Gao98,NULL,EX,<25 RTs (8 RTs),NULL
Gao98b,NULL,EX,<25 RTs (1 RTs),NULL
Garrido09,NULL,EX,<25 RTs,NULL
Gashnikova15,NULL,EX,<25 RTs,NULL
Gashnikova16,NULL,JIntAIDSSoc2020,,NULL
Gaspareto12,NULL,PLOSMED2015,,NULL
Gatanaga07,NULL,PLOSMED2015,Sequences are not in GB; Missing sequences in db;,NULL
Ghafari17,NULL,JIntAIDSSoc2020,,NULL
Gittens03,NULL,EX,<25 RTs (0 RTs),NULL
Gonsalez07,NULL,PLOSMED2015,,NULL
Gonzalez-Domenech18,NULL,EX,Outbreak,NULL
Gonzalez-Domenech20,NULL,New,,NULL
Gonzalez-Perez03,NULL,PLOSMED2015,Direct Genbank Submission,NULL
Gonzalez10,NULL,PLOSMED2015,Several DR lists were used.,NULL
Gordon03,NULL,PLOSMED2015,Study for Vaccine Developmemt,NULL
Graf11,NULL,PLOSMED2015,,NULL
Graf98,NULL,EX,<25 RTs (1 RTs),NULL
Grgic13,NULL,JIntAIDSSoc2020,Sequences available since 2013,NULL
Grossman05,NULL,PLOSMED2015,Middle East; SPREAD study,NULL
Guan20,NULL,New,,NULL
Gui15,NULL,EX,<25 Pts,NULL
Guimar10,NULL,EX,<25 Pts,NULL
Guimaraes15,NULL,JIntAIDSSoc2020,,NULL
Guimaraes15b,NULL,JIntAIDSSoc2020,,NULL
Gulick04,NULL,PLOSMED2015,Baseline of ACTG 5095,Use_Only_Untreated
Guo15,NULL,EX,Seq Leng,NULL
Gurtler94,NULL,EX,<25 RTs (1 RTs),NULL
Hachiya17,NULL,JIntAIDSSoc2020,,NULL
Hai-Long07,NULL,EX,<25 RTs (10 RTs),NULL
Hamers10,NULL,EX,Bigger study Hamers 2011 (ref1973) ,NULL
Hamers11,NULL,PLOSMED2015,The study includes 547 from Hamers10.,NULL
Han07,NULL,PLOSMED2015,Only 72 RTs in GB sequences.,NULL
Han10,NULL,PLOSMED2015,72 RTs and 91 PR linked to Ref1506 (Han 07 ARHR),NULL
Han13,NULL,EX,Rx not stated,NULL
Han13b,NULL,EX,<25 RTs (2 RTs),NULL
Han13c,NULL,EX,<25 Pts,NULL
Han13d,NULL,JIntAIDSSoc2020,Sequences available since 2014,NULL
Handema02,NULL,PLOSMED2015,,NULL
Hanke19,NULL,JIntAIDSSoc2020,,NULL
Hanke20,NULL,New,,NULL
Hanna03,NULL,PLOSMED2015,,NULL
Hao17,NULL,JIntAIDSSoc2020,,NULL
Harris03,NULL,EX,<25 RTs (6 RTs),NULL
Harris05,NULL,EX,<25 RTs (1 RTs),NULL
Hassan13,NULL,PLOSMED2015,,NULL
Hassan18,NULL,JIntAIDSSoc2020,,NULL
Hassan19,NULL,New,,NULL
Hattori10,NULL,PLOSMED2015,Survey from 2003 to 2008; 2003 sequences were published under Gatanaga07 (refid1768),NULL
Hattori16,NULL,JIntAIDSSoc2020,,NULL
Hawke13,NULL,PLOSMED2015,,NULL
Hebberecht20,NULL,New,,NULL
Heipertz13,NULL,PLOSMED2015,Several clusters,NULL
Heipertz16,NULL,EX,Rx not stated,NULL
Hernandez-Sanchez18,NULL,JIntAIDSSoc2020,,NULL
Herring01,NULL,EX,<25 Pts,NULL
Hierholzer02,NULL,EX,<25 RTs (10 RTs),NULL
Hierholzer02b,NULL,PLOSMED2015,"Arabic, North Africa; Study of subtypes",NULL
Hightower13,NULL,JIntAIDSSoc2020,Sequences available since 2014,NULL
Hingankar12,NULL,PLOSMED2015,"This study analyzed baseline sequences from 96 patients in Chennai and 96 patients in Mumbai who were starting 1-line regimen. The reported TDR was 5.2% in Chennai patients and 10.4% in Mumbai patients. In GB, only 96 from Chennai patients are available. Also the author noted that patients with previous ART exposure before initiating the 1-line were not excluded. This might have been the case for the Mumbai patients. Should we keep this study?",NULL
Hoelscher01,NULL,EX,<25 RTs (9 RTs),NULL
Hoenigl16,NULL,JIntAIDSSoc2020,,NULL
Holguin00,NULL,EX,<25 RTs (13 RTs),NULL
Holguin02,NULL,EX,<25 RTs (1 RTs),NULL
Holguin04,NULL,EX,<25 RTs (0 RTs),NULL
Holguin07,NULL,PLOSMED2015,,NULL
Holguin08,NULL,PLOSMED2015,,NULL
Holguin13,NULL,PLOSMED2015,Contacted: Holguin (aholguin.hciii@salud.madrid.org) for a paper; there seem to be multiple sequences from a same patient (look at CPR tree),NULL
Holzmayer05,NULL,EX,<25 RTs (1 RTs),NULL
Hora15,NULL,EX,Rx not stated,NULL
Hosaka16,NULL,EX,<25 Pts,NULL
Howard96,NULL,EX,<25 RTs (1 RTs),NULL
Hsi12,NULL,EX,<25 Pts,NULL
Huang03,NULL,EX,Not a representative study ,NULL
Huang06,NULL,EX,<25 RTs (3 RTs),NULL
Huang09,NULL,EX,<25 RTs (2 RTs),NULL
Huang09b,NULL,JIntAIDSSoc2020,Sequences available since 2016,NULL
Huik19,NULL,JIntAIDSSoc2020,,NULL
Hunt03,NULL,EX,<25 RTs (3 RTs),NULL
Hunt13,NULL,PLOSMED2015,Data from 9 WHO TS method surveys; 345 of the 354 were found in GB.,NULL
Hunt17,NULL,JIntAIDSSoc2020,,NULL
Huruy15,NULL,JIntAIDSSoc2020,,NULL
Huruy18,NULL,EX,Overlap with ref 2232,NULL
Iamarino12,NULL,EX,<25 RTs,NULL
Ibe08,NULL,PLOSMED2015,Most of M46I found in subtype B.,NULL
Ibe08b,NULL,EX,<25 RTs (12 RTs),NULL
Imade13,NULL,PLOSMED2015,34 of 38 pregnant women were sequenced. Modified WHO method was used (no age limitation),NULL
Inzaule18,NULL,EX,<25 RTs,NULL
Iqbal09,NULL,PLOSMED2015,55 AccessionIDs available but some of them are too short.,NULL
Irias19,NULL,JIntAIDSSoc2020,,NULL
Isarangkura-Na-Ayuthaya10,NULL,EX,<25 RTs,NULL
Ishizaki09,NULL,PLOSMED2015,,NULL
Iweriebor12,NULL,PLOSMED2015,,NULL
Jacobs08,NULL,PLOSMED2015,Only 91 RTs are in GB.,NULL
Jagdagsuren17,NULL,JIntAIDSSoc2020,Only 3 sequences are by NGS MiSeq,NULL
Jahanbakhsh12,NULL,PLOSMED2015,"96% were CRF35_AD; Samples from 47 of 50 naïve were sequenced; 94 Accessions in GB, PRRT and IN were submitted separately; Subtype for PRRT was changed to CRF35_AD and for IN was changed to A;",NULL
Jahanbakhsh13,NULL,EX,<25 Pts,NULL
Jayaraman06,NULL,PLOSMED2015,Not in GB; 715 in the paper; Only 399 in db.,NULL
Jia19,NULL,JIntAIDSSoc2020,,NULL
Jiamsakul15,NULL,EX,<25 RTs,NULL
Joao20,NULL,New,,NULL
Jonassen00,NULL,EX,<25 RTs (1 RTs),NULL
Jonassen97,NULL,EX,<25 RTs (1 RTs),NULL
Jorgensen03,NULL,PLOSMED2015,,NULL
Junqueira20,NULL,EX,<25 PTs,NULL
K'Aluoch05,NULL,PLOSMED2015,Direct Genbank Submission,NULL
Kamoto08,NULL,PLOSMED2015,"WHO HIVDR-TS Survey; All 54 sequences were available from this study, however, all 54 were not used to estimate TDR. 34 samples were good enough according to WhO HIVDR-TS sampling methodology. The sequence containing M46I would have been in the remainer of 20 sequences. ",NULL
Kandathil09,NULL,PLOSMED2015,The positions containing mutations rather than mutations themselves were counted.,NULL
Kane01,NULL,EX,<25 RTs (3 RTs),NULL
Kannangai15,NULL,JIntAIDSSoc2020,,NULL
Kao11,NULL,PLOSMED2015,Study of epidemiology: Outbreak of CRF07_BC (38%); Mostly env genes.,NULL
Karade16,NULL,EX,Previous ART exposed included; PMTCT included,NULL
Karade19,NULL,EX,<25 RTs,NULL
Karamov18,NULL,JIntAIDSSoc2020,,NULL
Karim10,NULL,EX,PrEX,NULL
Karlsson12,NULL,PLOSMED2015,Only 208 sequences are available in GB.,NULL
Kasang11,NULL,PLOSMED2015,Drug trace was found in two; Drug trace was not done for NRTIs; The two NNRTI trace mutant were removed.,NULL
Kassu07,NULL,PLOSMED2015,,NULL
Keita20,NULL,EX,<25 PTs,NULL
Kemal13,NULL,PLOSMED2015,143 GBs includes from plasma and PBMC of 30 women.,NULL
Kiertiburanakul13,NULL,PLOSMED2015,"1,798 patients (458 recent + 1,340 chronic-preART)",NULL
Kiguoya17,NULL,EX,<25 RTs,NULL
Kijak01,NULL,PLOSMED2015,Only 57 RT available in GB.,NULL
Kijak04,NULL,EX,Rx not stated,NULL
Kijak13,NULL,PLOSMED2015,"R144 Vaccine Trial; the samples used were from the volunteers who wer deferred from vaccine trial enrollment because of preexisting HIV infection; for 42 samples, full genome sequencing was done and all submitted to GB;",NULL
Kim11,NULL,EX,<25 RTs,NULL
Kinloch16,NULL,EX,Previous ART exposed included; 95% Naïve,NULL
Kinloch19,NULL,EX,<25 RTs,NULL
Kinomoto05,NULL,EX,<25 RTs (0 RTs),NULL
Kiptoo13,NULL,PLOSMED2015,,NULL
Kirichenko20,NULL,EX,<25 RTs,NULL
Kiros20,NULL,New,,NULL
Kityo16,NULL,EX,Pediatric,NULL
Koch01,NULL,EX,<25 RTs (18 RTs),NULL
Koizumi06,NULL,EX,Cloned,NULL
Kojima08,NULL,EX,<25 RTs,NULL
Konings04,NULL,EX,<25 RTs (0 RTs),NULL
Konings04b,NULL,EX,<25 RTs (12 RTs),NULL
Konou16,NULL,JIntAIDSSoc2020,,NULL
Kostaki18,NULL,JIntAIDSSoc2020,,NULL
Kostaki19,NULL,EX,ARV status for the 2nd cohort is not available,NULL
Kotaki13,NULL,EX,<25 RTs,NULL
Kotaki15,NULL,JIntAIDSSoc2020,,NULL
Koulinska01,NULL,EX,<25 RTs (3 RTs),NULL
Koulinska02,NULL,EX,<25 RTs (4 RTs),NULL
Kouri15,NULL,JIntAIDSSoc2020,,NULL
Kousiappa09,NULL,PLOSMED2015,,NULL
Kousiappa11,NULL,EX,Only 30% were treatment-naive; Rx should be corrected with the author; Emailed to the author (lkostrik@ucy.ac.cy);,NULL
Kroon18,NULL,JIntAIDSSoc2020,,NULL
Kumar14,NULL,EX,Pediatric,NULL
Kusagawa15,NULL,EX,<25 Pts,NULL
Laeyendecker05,NULL,EX,<25 RTs (0 RTs),NULL
Lahuerta08,NULL,EX,<25 RTs (0 RTs),NULL
Lall08,NULL,PLOSMED2015,"The author stated that ""It is possible that the relatively high rates (10%) of drug resistance observed in this study may be due to study participants who had previous exposure to ART unknowingly declaring themselves ART naive.""",NULL
Lama06,NULL,PLOSMED2015,,Use_Only_Untreated
Lan03,NULL,PLOSMED2015,Only 175 RTs in Genbank.,NULL
Lan20,NULL,EX,<25 PTs,NULL
Land08,NULL,EX,<25 RTs (10 RTs),NULL
Lataillade07,NULL,EX,<25 RTs,NULL
Lau07,NULL,EX,<25 Pts,NULL
Lavu17,NULL,JIntAIDSSoc2020,,NULL
Lawrence06,NULL,EX,SeqLength up to 203,NULL
Lazaro11,NULL,PLOSMED2015,M46I was classified as a polymorphism.,NULL
Lebedev17,NULL,EX,Rx not stated,NULL
Lee09,NULL,PLOSMED2015,,NULL
Lee14,NULL,EX,Previous ART exposed included; Previous PMTCT not known,NULL
Lee16,NULL,EX,<25 Pts,NULL
Leoz11,NULL,EX,<25 Pts,NULL
Leoz13,NULL,EX,<25 RTs (3 RTs),NULL
Li05,NULL,EX,Rx not stated,NULL
Li07,NULL,EX,<25 RTs (18 RTs),NULL
Li10,NULL,EX,<25 RTs (1 RTs),NULL
Li11,NULL,EX,<25 Pts,NULL
Li13,NULL,PLOSMED2015,MSMs in Beijing; All four (5.3%) had M46L and all closely related phylogentically;,NULL
Li13b,NULL,EX,<25 RTs (3 RTs),NULL
Li13c,NULL,PLOSMED2015,,NULL
Li13d,NULL,PLOSMED2015,pol genes from 98 patients,NULL
Li14,NULL,EX,<25 Pts,NULL
Li15,NULL,JIntAIDSSoc2020,,NULL
Li15b,NULL,JIntAIDSSoc2020,,NULL
Li15c,NULL,JIntAIDSSoc2020,,NULL
Li16,NULL,JIntAIDSSoc2020,,NULL
Li16b,NULL,JIntAIDSSoc2020,,NULL
Li18,NULL,JIntAIDSSoc2020,,NULL
Liang20,NULL,New,,NULL
Liao07,NULL,PLOSMED2015,,NULL
Liao09,NULL,PLOSMED2015,Study of epidemiology,NULL
Liegler14,NULL,EX,PrEX,NULL
Lihana09,NULL,JIntAIDSSoc2020,Sequences available since 2016,NULL
Liitsola00,NULL,EX,<25 RTs (3 RTs),NULL
Lima16,NULL,JIntAIDSSoc2020,,NULL
Lin07,NULL,EX,<25 RTs (4 RTs),NULL
Lin13,NULL,JIntAIDSSoc2020,,NULL
Lindstrom06,NULL,PLOSMED2015,,NULL
Little02,NULL,PLOSMED2015,,NULL
Little14,NULL,JIntAIDSSoc2020,,NULL
Liu05,NULL,EX,<25 RTs (3 RTs),NULL
Liu07,NULL,EX,<25 RTs (0 RTs),NULL
Liu12,NULL,EX,<25 Pts,NULL
Liu15,NULL,EX,<25 Pts,NULL
Lloyd08,NULL,PLOSMED2015,"Central America; The author stated that 69% were confirmed as ""Na•ve""; ",NULL
Lole99,NULL,EX,<25 RTs (5 RTs),NULL
Loubet14,NULL,EX,Previous ART exposed included; PMTCT included,NULL
Lu15,NULL,JIntAIDSSoc2020,,NULL
Lu16,NULL,EX,<25 Pts,NULL
Lu17,NULL,JIntAIDSSoc2020,,NULL
Lu18,NULL,JIntAIDSSoc2020,,NULL
Lu19,NULL,JIntAIDSSoc2020,,NULL
Luk01,NULL,EX,<25 RTs (0 RTs),NULL
Luk07,NULL,EX,<25 RTs (3 RTs),NULL
Luk08,NULL,EX,<25 RTs (1 RTs),NULL
Luk15,NULL,EX,Rx not stated,NULL
Lunar13,NULL,PLOSMED2015,150 analyzed (120 new + 30 linked to ref1724 Spread) ,NULL
Lunar15,NULL,JIntAIDSSoc2020,,NULL
Lunar18,NULL,JIntAIDSSoc2020,,NULL
Lunar19,NULL,EX,<25 Pts,NULL
Lunar20,NULL,EX,<25 PTs,NULL
Luu12,NULL,EX,<25 RTs,NULL
Ly05,NULL,PLOSMED2015,,NULL
Machado02,NULL,PLOSMED2015,Mostly from US. ,Set_Continent_To: Europe
Machado09,NULL,EX,<25 RTs (0 RTs),NULL
Machado12,NULL,PLOSMED2015,"Some RTs were not up to 240, excluded from CPR analysis; Some SDRMs(L33F and M46L) not found in GB sequences.",NULL
Machado19,NULL,JIntAIDSSoc2020,,NULL
Macharia16,NULL,JIntAIDSSoc2020,,NULL
Machnowska19,NULL,JIntAIDSSoc2020,,NULL
Maljkovic03,NULL,PLOSMED2015,,NULL
Mamadou03,NULL,EX,<25 RTs (3 RTs),NULL
Manasa11,NULL,PLOSMED2015,,NULL
Marechal06,NULL,PLOSMED2015,,NULL
Margot19,NULL,EX,<25 RTs,NULL
Maruapula20,NULL,New,,NULL
Masharsky03,NULL,EX,<25 RTs (2 RTs),NULL
Masimba13,NULL,PLOSMED2015,Only 226 in GB,NULL
Masoud20,NULL,EX,<25 RTs,NULL
Matthews08,NULL,JIntAIDSSoc2020,Sequences available since 2016,NULL
Mazzuti20,NULL,New,,NULL
Mbange18,NULL,JIntAIDSSoc2020,Only 85 sequences were submitted; Modified WHO TS method,NULL
Mbisa20,NULL,New,,NULL
McClutchan02,NULL,EX,<25 RTs (1 RTs),NULL
McConnell08,NULL,PLOSMED2015,,NULL
McCutchan04,NULL,EX,<25 RTs (4 RTs),NULL
McIntosh91,NULL,EX,<25 RTs (1 RTs),NULL
McLaughlin04,NULL,EX,<25 RTs (4 RTs),NULL
McNulty07,NULL,EX,<25 Pts,NULL
Megasari19,NULL,JIntAIDSSoc2020,,NULL
Megede02,NULL,EX,<25 RTs (3 RTs),NULL
Meixenberger14,NULL,JIntAIDSSoc2020,,NULL
Meixenberger17,NULL,EX,<25 RTs,NULL
Meloni04,NULL,EX,<25 RTs (5 RTs),NULL
Memarnejadian15,NULL,JIntAIDSSoc2020,,NULL
Memarnejadian18,NULL,JIntAIDSSoc2020,,NULL
Meng13,NULL,EX,<25 Pts,NULL
Mezei11,NULL,PLOSMED2015,,NULL
Mikasi17,NULL,EX,<25 RTs,NULL
Mikasi20,NULL,EX,<25 RTs,NULL
Milne19,NULL,EX,Previous ART exposed included; PMTCT (40%) included,NULL
Mintsa-Ndong09,NULL,EX,<25 RTs (15 RTs),NULL
Miri11,NULL,EX,<25 RTs (0 RTs),NULL
Misbah13,NULL,EX,<25 RTs,NULL
Miura08,NULL,PLOSMED2015,IsolateYears were received from Pereyra; Contacted: Emailed to Pereyra(fpereyra@partners.org) JID 2008 for isolate years; 95 HIV-1 elite controller (long-term nonprogressors); 41 RT; Isolate Year not found,NULL
Mokili02,NULL,EX,<25 RTs (1 RTs),NULL
Monleau12,NULL,EX,<25 RTs,NULL
Montavon02,NULL,EX,<25 RTs (2 RTs),NULL
Montavon02b,NULL,EX,<25 RTs (3 RTs),NULL
Montavon99,NULL,EX,<25 RTs (1 RTs),NULL
Mor19,NULL,EX,<25 RTs,NULL
Mosha10,NULL,PLOSMED2015,,NULL
Moskaleychik15,NULL,EX,<25 Pts,NULL
Moura15,NULL,JIntAIDSSoc2020,,NULL
Moura15b,NULL,JIntAIDSSoc2020,,NULL
Msimanga15,NULL,EX,<25 Pts,NULL
Mulu13,NULL,PLOSMED2015,,NULL
Mulu15,NULL,EX,<25 RTs,NULL
Murillo12,NULL,PLOSMED2015,"Two out of 119 were not ARV-naïve so excluded from the TDR estimation in the paper but we don't know which are the two. Because the two had no DRMs, our TDR estimation is lower than what they had;",NULL
Musyoki12,NULL,PLOSMED2015,Study for Vaccine.,NULL
Nadai09,NULL,PLOSMED2015,,NULL
Nanfack17,NULL,JIntAIDSSoc2020,,NULL
Nazziwa12,NULL,PLOSMED2015,Each of 3 of 46 (6%) contains one NNRTI DRM,NULL
Ndase12,NULL,JIntAIDSSoc2020,Sequences available since 2014,NULL
Ndembi08,NULL,PLOSMED2015,79 sequences include group three O and 1 HIV2; Some of the mutations reported in the paper do not exist in the genbank sequences.,NULL
Ndembi08b,NULL,PLOSMED2015,WHO HIVDR-TS Survey,NULL
Ndembi11,NULL,PLOSMED2015,WHO HIVDR-TS Survey,NULL
Ndongmo06,NULL,EX,<25 RTs (0 RTs),NULL
Nduva20,NULL,New,,NULL
Neilson99,NULL,EX,<25 RTs (2 RTs),NULL
Neogi10,NULL,EX,<25 RTs (21 RTs),NULL
Neogi11,NULL,EX,<25 RTs,NULL
Neogi15,NULL,JIntAIDSSoc2020,,NULL
Nesakumar19,NULL,JIntAIDSSoc2020,,NULL
Ng11,NULL,EX,<25 RTs (0 RTs),NULL
Ng11b,NULL,EX,<25 RTs (3 RTs),NULL
Ngo-Giang-Huong19,NULL,EX,Previous ART exposed included; ART-exposed (7%),NULL
Nguyen08,NULL,PLOSMED2015,WHO HIVDR-TS Survey,NULL
Niama09,NULL,EX,<25 RTs (4 RTs),NULL
Niculescu14,NULL,JIntAIDSSoc2020,,NULL
Njai06,NULL,PLOSMED2015,Study of subtypes,NULL
Njouom03,NULL,EX,Excluded Previously (SampleYear),NULL
Nkengasong00,NULL,EX,<25 RTs (0 RTs),NULL
Nomura13,NULL,EX,<25 RTs,NULL
Nouhin09,NULL,PLOSMED2015,,NULL
Nouhin11,NULL,EX,<25 RTs,NULL
Novitsky02,NULL,EX,Cloned; No statement of All Untreated,NULL
Novitsky15,NULL,EX,Rx not stated; Included VS pts,NULL
Novitsky99,NULL,EX,<25 RTs (8 RTs),NULL
Novitsky99b,NULL,EX,<25 RTs (1 RTs),NULL
Ntemgwa08,NULL,EX,<25 RTs (1 RTs),NULL
Nwobegahay11,NULL,PLOSMED2015,,NULL
Nwobegahay11b,NULL,PLOSMED2015,,NULL
Nwobegahay12,NULL,PLOSMED2015,,NULL
Nzeyimana10,NULL,EX,Previous ART exposed included,NULL
Oelrichs98,NULL,EX,<25 RTs (1 RTs),NULL
Oelrichs99,NULL,EX,<25 RTs (1 RTs),NULL
Oette06,NULL,PLOSMED2015,Sequences are not in GB.,NULL
Ojesina06,NULL,EX,Excluded Previously (SampleYear),NULL
Ojwach18,NULL,JIntAIDSSoc2020,,NULL
Oliveira12,NULL,EX,<25 RTs,NULL
Ong13,NULL,PLOSMED2015,,NULL
OnoriodeDigban19,NULL,EX,<25 RTs,NULL
Onoro07,NULL,PLOSMED2015,The paper in Spanish; Sequences are not in GB; Samples from 2002 - 2005; No individual IsolateYear info available;,NULL
Onsongo16,NULL,EX,<25 RTs,NULL
Onywera17,NULL,JIntAIDSSoc2020,,NULL
Oroz19,NULL,New,,NULL
Otecko16,NULL,JIntAIDSSoc2020,,NULL
Palacios08,NULL,PLOSMED2015,The paper in Spanish.,NULL
Palm15,NULL,EX,<25 Pts,NULL
Palma07,NULL,PLOSMED2015,SPREAD study,NULL
Pandey16,NULL,EX,<25 Pts,NULL
Pando06,NULL,EX,<25 RTs (10 RTs),NULL
Pandrea01,NULL,EX,<25 RTs (6 RTs),NULL
Pandrea02,NULL,PLOSMED2015,Study of recombinants,NULL
Panichsillapakit16,NULL,JIntAIDSSoc2020,,NULL
Paolucci14,NULL,EX,<25 RTs,NULL
Papathanasopoulos02,NULL,EX,<25 RTs (4 RTs),NULL
Papathanasopoulos03,NULL,EX,<25 RTs (2 RTs),NULL
Papathanasopoulos10,NULL,PLOSMED2015,,NULL
Paraschiv07,NULL,PLOSMED2015,Study of subtype F,NULL
Paraschiv17,NULL,JIntAIDSSoc2020,,NULL
Paraskevis00,NULL,EX,<25 RTs (1 RTs),NULL
Paraskevis01,NULL,EX,<25 RTs (1 RTs),NULL
Paraskevis05,NULL,PLOSMED2015,SPREAD study,NULL
Parboosing11,NULL,PLOSMED2015,WHO HIVDR-TS Survey,NULL
Parczewski14,NULL,JIntAIDSSoc2020,,NULL
Parham11,NULL,New,,NULL
Pariente04,NULL,EX,Excluded Previously (SampleYear),NULL
Park03,NULL,PLOSMED2015,,NULL
Parreira04,NULL,EX,<25 RTs (0 RTs),NULL
Parreira06,NULL,PLOSMED2015,"131 naïve patients, 43 pol sequences",NULL
Passaes09,NULL,EX,<25 RTs,NULL
Patino-Galindo17,NULL,New,,NULL
Perez-Parra16,NULL,JIntAIDSSoc2020,,NULL
Perez-Parra17,NULL,New,,NULL
Perno01,NULL,PLOSMED2015,Study of baseline mutations associated to outcomes,NULL
Pessoa15,NULL,JIntAIDSSoc2020,,NULL
Pessoa16,NULL,EX,NGS,NULL
Pessôa14,NULL,EX,<25 RTs,NULL
Petch05,NULL,EX,<25 RTs (21 RTs),NULL
Petroni06,NULL,PLOSMED2015,,NULL
Pham15,NULL,JIntAIDSSoc2020,,NULL
Phan10,NULL,PLOSMED2015,,NULL
Phung16,NULL,EX,Pediatric,NULL
Pieniazek04,NULL,EX,<25 RTs (0 RTs),NULL
Pieniazek98,NULL,EX,<25 RTs (0 RTs),NULL
Pillay02,NULL,PLOSMED2015,NULL,NULL
Pillay08,NULL,PLOSMED2015,WHO HIVDR-TS Survey,NULL
Pires04,NULL,PLOSMED2015,,NULL
Piyasirisilp00,NULL,EX,<25 RTs (5 RTs),NULL
Plantier09,NULL,EX,<25 RTs (1 RTs),NULL
Pollakis03,NULL,EX,<25 Pts,NULL
Powell07,NULL,EX,<25 RTs (2 RTs),NULL
Powell07b,NULL,EX,<25 RTs (1 RTs),NULL
Price11,NULL,PLOSMED2015,The 280 extra sequences are included in the author's next paper. We need to separate them out when the new paper is published.,NULL
Punzi05,NULL,EX,<25 RTs (2 RTs),NULL
Qi13,NULL,EX,Seq Leng,NULL
Qiu05,NULL,EX,<25 RTs (5 RTs),NULL
Ragonnet-Cronin10,NULL,PLOSMED2015,Study of Cluster Dynamics.,NULL
Ragonnet-Cronin12,NULL,PLOSMED2015,Study of a new method for estimating the time of infection; Study includes 535 new sequences and 776 from Ragonnet-Cronin10 (ref1791);,NULL
Ragonnet-Cronin12b,NULL,PLOSMED2015,"Study of HLA Epitopes; According to the paper, this study includes 483 new sequences, 779 from Ragonnet-Cronin10 (Ref1791) and 535 from Ragonnet-Cronin12 (ref2021);",NULL
Ragonnet-Cronin18,NULL,EX,<25 PTs,NULL
Ramos03,NULL,EX,<25 RTs (4 RTs),NULL
Rasmussen18,NULL,JIntAIDSSoc2020,,NULL
Ravuri06,NULL,EX,Excluded Previously (Unpublished),NULL
Razafindratsimandresy06,NULL,PLOSMED2015,,NULL
Razafindratsimandresy07,NULL,PLOSMED2015,,NULL
Reigadas13,NULL,EX,<25 RTs,NULL
Reinke01,NULL,EX,<25 Pts,NULL
Reis19,NULL,EX,<25 PTs,NULL
Reynolds16,NULL,EX,<25 Pts,NULL
Rhee15,NULL,PLOSMED2015,"Kaiser, 2003 to 2006",NULL
Rhee19,NULL,JIntAIDSSoc2020,KP TDR 2007 to 2017,NULL
Roberts15,NULL,JIntAIDSSoc2020,,NULL
Rodgers17,NULL,EX,<25 Pts,NULL
Rodgers20,NULL,EX,<25 RTs,NULL
Rodrigues06,NULL,PLOSMED2015,,NULL
Rodriguez06b,NULL,EX,<25 RTs (1 RTs),NULL
Rolland11,NULL,PLOSMED2015,Step trial (vaccine); Mostly from N. America,NULL
Rolland12,NULL,PLOSMED2015,R144 Vaccine Trial; the samples used were from 110 volunteers who got infected during the trial; 1359 GBs were from 121 pts according to GB annotation; ,NULL
Romano00,NULL,PLOSMED2015,,NULL
Ross14,NULL,JIntAIDSSoc2020,,NULL
Roudinskii04,NULL,EX,<25 RTs (0 RTs),NULL
Rousseau06,NULL,EX,Cloned,NULL
Rudovick18,NULL,EX,Previous ART exposed included; PMTCT included,NULL
Rutvisuttinunt12,NULL,EX,<25 Pts,NULL
Sa-Filho07,NULL,EX,<25 RTs (12 RTs),NULL
Saad05,NULL,EX,<25 RTs (19 RTs),NULL
Saad06,NULL,PLOSMED2015,A Former Soviet Union,Use_Only_Untreated
Saad06b,NULL,PLOSMED2015,A Former Soviet Union,NULL
Sachithanandham16,NULL,EX,<25 RTs,NULL
Sacks-Davis20,NULL,New,,NULL
Saeng-Aroon16,NULL,JIntAIDSSoc2020,,NULL
Sagoe07,NULL,PLOSMED2015,,NULL
Sagoe12,NULL,EX,<25 Pts,NULL
Sagoe16,NULL,EX,<25 Pts,NULL
Sahbandar09,NULL,EX,<25 RTs (3 RTs),NULL
Salminen96,NULL,EX,<25 RTs (1 RTs),NULL
Salvana14,NULL,JIntAIDSSoc2020,,NULL
Sanabani11,NULL,PLOSMED2015,Only 51 sequences are available in GB.,NULL
Sanders-Buell07,NULL,EX,<25 RTs (4 RTs),NULL
Sanders-Buell10,NULL,EX,<25 RTs (11 RTs),NULL
Sandstrom05,NULL,EX,Cloned,NULL
Santos11,NULL,PLOSMED2015,"DRMs in 3 prime RT subdomains; 341 GB from 204 naive patients in city of Rio Grande, southern Brazil; 88 RTs;",NULL
Seatla19,NULL,EX,<25 RTs,NULL
Sebastião19,NULL,New,,NULL
Selimova10,NULL,PLOSMED2015,,NULL
Seoighe07,NULL,PLOSMED2015,Baseline of sdNVP Pregnant women;Sstudy of selection by sdNVP,Use_Only_Untreated
Serrano12,NULL,PLOSMED2015,Direct Genbank Submission; CDC study,NULL
Servais01,NULL,EX,<25 RTs (0 RTs),NULL
Servais04,NULL,PLOSMED2015,,NULL
Shafer03,NULL,PLOSMED2015,Baseline sequences from ACTG 384 are included.,Use_Only_Untreated
Shafer97,NULL,EX,<25 RTs (12 RTs),NULL
Shafer99,NULL,EX,<25 RTs (0 RTs),NULL
Shahid11,NULL,EX,<25 RTs (6 RTs),NULL
Shi04,NULL,EX,<25 RTs (1 RTs),NULL
Sigaloff12,NULL,PLOSMED2015,10 years after Roll-out began,NULL
Silva16,NULL,JIntAIDSSoc2020,,NULL
Silva20,NULL,New,,NULL
Simon02,NULL,PLOSMED2015,,NULL
Simonetti14,NULL,EX,<25 Pts,NULL
Sinha12,NULL,PLOSMED2015,Only 31 sequences are available in GB.,NULL
Sirivichayakul01,NULL,PLOSMED2015,Study of epidemiology; ART started in 1988 in Thailand; IDV was a the preferred PI in the early years (Sirvichayakul08).,NULL
Sirivichayakul08,NULL,PLOSMED2015,WHO HIVDR-TS sampling,NULL
Sivay20,NULL,New,,NULL
Sivay20b,NULL,EX,<25 PTs,NULL
Skinner98,NULL,EX,<25 Pts,NULL
Smith09,NULL,PLOSMED2015,,NULL
Smolen-Dzirba12,NULL,PLOSMED2015,One of 54 had many Apobec mutations,NULL
Smolen-Dzirba17,NULL,JIntAIDSSoc2020,,NULL
Soares03,NULL,PLOSMED2015,Study of Brazilian subtype C,NULL
Soares10,NULL,PLOSMED2015,"Of 59, one is group O and 49 encode RT; 6% includes polymorphic mutations and RNaseH domain mutations.",NULL
Soheilli09,NULL,EX,<25 RTs (8 RTs),NULL
Somda12,NULL,PLOSMED2015,,NULL
Somi08,NULL,PLOSMED2015,WHO HIVDR-TS Survey; M46L and F53Y were not included in SDRM2007 list. ,NULL
Song16,NULL,EX,<25 Pts,NULL
Song20,NULL,EX,<25 PTs,NULL
Soria12,NULL,PLOSMED2015,,NULL
Soria19,NULL,JIntAIDSSoc2020,,NULL
Soto-Ramirez96,NULL,EX,<25 RTs (5 RTs),NULL
Soundararajan07,NULL,EX,Pediatric,NULL
Ssemwanga12,NULL,PLOSMED2015,Seroconverters identified in a prevalent case study for a rural area,NULL
Ssemwanga12b,NULL,PLOSMED2015,40 of 42 were sequenced,NULL
Stanojevic13,NULL,PLOSMED2015,Dr. Stanojevic sent us this for our surveillance study; She included these sequences in Siljic 2013 study with treated samples.,NULL
Steegen16,NULL,JIntAIDSSoc2020,,NULL
Stekler14,NULL,EX,<25 RTs,NULL
Struck07,NULL,EX,<25 RTs (20 RTs),NULL
Struck15,NULL,EX,<25 Pts,NULL
Su03,NULL,EX,<25 RTs (3 RTs),NULL
Su11,NULL,PLOSMED2015,,NULL
Su16,NULL,EX,<25 Pts,NULL
Sucupira07,NULL,JIntAIDSSoc2020,Sequences available since 2016,NULL
Sun19,NULL,JIntAIDSSoc2020,,NULL
Swanson03,NULL,EX,<25 RTs (1 RTs),NULL
Tamalet18,NULL,JIntAIDSSoc2020,,NULL
Tamalet18b,NULL,JIntAIDSSoc2020,,NULL
Tanaka19,NULL,JIntAIDSSoc2020,,NULL
Tanuma13,NULL,EX,Population not described,NULL
Tanuri99,NULL,EX,<25 RTs (0 RTs),NULL
Tatsumi06,NULL,EX,<25 RTs (6 RTs),NULL
Tchiakpe20,NULL,New,,NULL
Tchouwa18,NULL,EX,Previous ART exposed included; ART-exposed (10%),NULL
Tebit02,NULL,EX,<25 RTs (1 RTs),NULL
Tebit06,NULL,EX,<25 RTs (0 RTs),NULL
Tebit09,NULL,PLOSMED2015,"The author stated that 'It is also worth noting that the present study was carried out in an urban setting, where more patients are under treatment or exposed to HIV drugs. Cases of patients sharing medications are observed in such settings hence prior ART use cannot be ruled out completely in this reportedly drug-naõve group.'",NULL
Tee05,NULL,PLOSMED2015,Study of subtypes,NULL
Tee05b,NULL,PLOSMED2015,Study of subtypes,NULL
Tee06,NULL,EX,<25 RTs (8 RTs),NULL
Tee09,NULL,EX,<25 Pts,NULL
Tee17,NULL,EX,<25 Pts,NULL
Teixeira06,NULL,PLOSMED2015,65 ARV-na•ves include 27 from pre-HAART era and 38 from post-HAART era; TDR rates were reported separately for each two groups for each drug class.,NULL
Telan11,NULL,EX,<25 RTs (22 RTs),NULL
Telan12,NULL,PLOSMED2015,Need ART rollout year; Contacted: skageyama@med.tottori-u.ac.jp,NULL
Telele18,NULL,EX,Previous ART exposed included; did not state whether self-reported ART-exposed was excluded,NULL
Temereanca12,NULL,PLOSMED2015,Contacted: Simona Ruta (simona@simonaruta.ro) for isolation year; the paper states that the 61 sequences were from 1997 to 2011; Only 50 in GB;,NULL
Temereanca17,NULL,New,,NULL
Thao12,NULL,JIntAIDSSoc2020,Sequences available since 2016,NULL
Thomson02,NULL,EX,<25 RTs (8 RTs),NULL
Thomson05,NULL,EX,<25 RTs (1 RTs),NULL
Thorat11,NULL,PLOSMED2015,,NULL
Tongo15,NULL,EX,<25 Pts,NULL
Toni02,NULL,PLOSMED2015,,NULL
Toni03,NULL,PLOSMED2015,96 RTs in GB; The study had more sequences and reported fewer mutations (ie. one K219Q and two K219N).,NULL
Toni05,NULL,EX,<25 RTs (6 RTs),NULL
Toni07,NULL,PLOSMED2015,Only 87 RTs in GB.,NULL
Totmenin19,NULL,EX,<25 RTs,NULL
Totmenin19b,NULL,EX,<25 RTs,NULL
Tovanabutra01,NULL,EX,<25 RTs (1 RTs),NULL
Tovanabutra03,NULL,EX,<25 RTs (3 RTs),NULL
Tovanabutra04,NULL,PLOSMED2015,Study of epidemiology,NULL
Tovanabutra05,NULL,EX,<25 RTs (12 RTs),NULL
Tovanabutra07,NULL,EX,<25 RTs (3 RTs),NULL
Tovanabutra10,NULL,EX,<25 RTs (21 RTs),NULL
Tramuto13,NULL,EX,Previously excluded; Large overlap with Bonura10 (Ref 1780),NULL
Tran12,NULL,PLOSMED2015,,NULL
Trinh12,NULL,PLOSMED2015,"Children - sdNVP exclusion? PMPTC was not discussed in the paper, however, it says ""HIV-1 DRMs that were identified in the viruses from the infants and children in this study may have been primary or transmitted from mothers who had primary or transmitted DRMs or who acquired DRMs from unrecorded antiviral treatments.""; 4 RT sequences were excluded by CPR (APOBEC mutations)",NULL
Triques00,NULL,EX,<25 RTs (4 RTs),NULL
Truong06,NULL,EX,A bigger study refid 1959 ,NULL
Truong11,NULL,PLOSMED2015,,NULL
Tscherning-Casper00,NULL,EX,<25 RTs (0 RTs),NULL
Tshabalala11,NULL,PLOSMED2015,The study includes 56 sequences from Dalai09 (Ref1714). ,NULL
Tsuiji06,NULL,EX,<25 RTs (20 RTs),NULL
Tu09,NULL,PLOSMED2015,,NULL
Tully16,North America,EX,NGS,NULL
Tully16,Europe,EX,NGS,NULL
Tymchuk10,NULL,EX,<25 RTs (20 RTs),NULL
Tzitzivacos09,NULL,EX,<25 Pts,NULL
Ugbena12,NULL,PLOSMED2015,Baseline samples from 271 patients and 18 followup sequences; Only baseline sequences were in GB.,NULL
Vahabpour17,NULL,JIntAIDSSoc2020,,NULL
Valle-Bahena06,NULL,PLOSMED2015,,NULL
Vallejo98,NULL,EX,<25 RTs (0 RTs),NULL
VanLaethem08,NULL,EX,<25 RTs,NULL
VanTran16,NULL,JIntAIDSSoc2020,,NULL
Varella07,NULL,PLOSMED2015,Sequences are not in GB; Only 50 in db.,NULL
Varghese10,NULL,EX,<25 RTs,NULL
Vaughan03,NULL,PLOSMED2015,Caribbean; WHO's regional office study,NULL
Vaz12,NULL,EX,Pediatric,NULL
Vercauteren08,NULL,PLOSMED2015,SPREAD study,NULL
Vercauteren09,NULL,PLOSMED2015,SPREAD study; 2198 in GB;,Set_Continent_To: Europe
Vergne00,NULL,PLOSMED2015,"142 sequences were analyzed: 62 from Cameroon, 38 from Senegal, 18 from DRC and 24 from France. Four  sequences were group O (114 group M). The study reported Major DRM containing sequences which include the four group O sequences and one from France containing V108I. There were one sequence containing M41L and T215D and another one containing M46I from France, however, these mutations were classified as Minor DRM in the study. ",NULL
Vergne06,NULL,EX,<25 RTs (19 RTs),NULL
Vergne06b,NULL,PLOSMED2015,,NULL
Verhofstede17,NULL,EX,Naive not distinguishable,NULL
Vessiere06,NULL,PLOSMED2015,,NULL
Vessiere10,NULL,EX,<25 RTs (1 RTs),NULL
Viani06,NULL,PLOSMED2015,Mostly from US (1/55 is from Pueto Rico).,Set_Continent_To: North America
Vicente01,NULL,EX,<25 RTs (0 RTs),NULL
Vicenti07,NULL,PLOSMED2015,Study of PBMC vs Plasma,NULL
Vidal00,NULL,EX,<25 RTs (1 RTs),NULL
Vidal03,NULL,EX,<25 RTs (4 RTs),NULL
Vidal06,NULL,PLOSMED2015,,NULL
Vidal06b,NULL,EX,<25 RTs (3 RTs),NULL
Vidal07,NULL,PLOSMED2015,,NULL
Vidal08,NULL,EX,<25 RTs (2 RTs),NULL
Vidal09,NULL,EX,<25 Pts,NULL
Vignoles07,NULL,EX,Pediatric,NULL
Vinogradova10,NULL,PLOSMED2015,A Former Soviet Union; Mainly subtype A.,NULL
Viputtijul02,NULL,EX,<25 RTs (1 RTs),NULL
Visawapoka06,NULL,EX,<25 RTs (4 RTs),NULL
Vubil16,NULL,JIntAIDSSoc2020,,NULL
Wahid16,NULL,JIntAIDSSoc2020,,NULL
Wang08,NULL,PLOSMED2015,Study of subtypes,NULL
Wang09,NULL,PLOSMED2015,98 pts in the paper but 91 GB;,NULL
Wang15,NULL,EX,Rx not stated,NULL
Wang15b,NULL,JIntAIDSSoc2020,,NULL
Wang15c,NULL,EX,Rx not stated,NULL
Wang18,NULL,JIntAIDSSoc2020,,NULL
Wang18b,NULL,JIntAIDSSoc2020,,NULL
Wang19,NULL,New,,NULL
Warachit07,NULL,EX,<25 RTs (1 RTs),NULL
Watanaveeradej03,NULL,EX,<25 RTs (1 RTs),NULL
Watanaveeradej06,NULL,EX,Seq QA problem,NULL
Wei13,NULL,EX,<25 Pts,NULL
Wei14,NULL,EX,<25 Pts,NULL
Wei14b,NULL,EX,<25 Pts,NULL
Weng16,NULL,JIntAIDSSoc2020,,NULL
Wilantho11,NULL,EX,<25 RTs,NULL
Wilbe02,NULL,EX,<25 RTs (4 RTs),NULL
Wilhelmson18,NULL,EX,Previous ART exposed included; Women with previous pregnancy (50%) included,NULL
Willliamson03,NULL,EX,Excluded Previously (SampleYear),NULL
Winslow95,NULL,EX,<25 RTs (0 RTs),NULL
Witaningrum16,NULL,JIntAIDSSoc2020,,NULL
Worobey16,NULL,EX,<25 Pts,NULL
Wright10,NULL,EX,<25 RTs (0 RTs),NULL
Wright11,NULL,EX,<25 RTs (0 RTs),NULL
Wu13,NULL,PLOSMED2015,131 samples of 138 MSMs were sequenced; 133 in GB;,NULL
Wu15,NULL,JIntAIDSSoc2020,,NULL
Wu19,NULL,New,,NULL
Wu20,NULL,New,,NULL
Xie20,NULL,EX,<25 PTs,NULL
Xu18,NULL,JIntAIDSSoc2020,,NULL
Xuan18,NULL,JIntAIDSSoc2020,,NULL
Yamaguchi03,NULL,EX,<25 RTs (15 RTs),NULL
Yamaguchi09,NULL,EX,<25 RTs (5 RTs),NULL
Yamaguchi10,NULL,EX,<25 RTs (1 RTs),NULL
Yamaguchi19,NULL,EX,<25 PTs,NULL
Yamaguchi95,NULL,EX,<25 RTs (0 RTs),NULL
Yan15,NULL,JIntAIDSSoc2020,,NULL
Yang00,NULL,EX,<25 RTs (0 RTs),NULL
Yang02,NULL,PLOSMED2015,Study of subtypes,NULL
Yang03,NULL,EX,<25 RTs (5 RTs),NULL
Yang04,NULL,PLOSMED2015,Study of recombinants,NULL
Yang11,NULL,PLOSMED2015,Direct Genbank Submission; CDC study,NULL
Yang12,NULL,PLOSMED2015,,NULL
Yang20,NULL,EX,<25 PTs,NULL
Yao15,NULL,JIntAIDSSoc2020,,NULL
Yao15b,NULL,EX,Rx not stated,NULL
Yaotse09,NULL,PLOSMED2015,,NULL
Yaqub19,NULL,EX,<25 PTs,NULL
Ye11,NULL,PLOSMED2015,Study of BC recombinants,NULL
Ye12,NULL,EX,Previous ART exposed included,NULL
Ye14,NULL,JIntAIDSSoc2020,,NULL
Ye20,NULL,New,,NULL
Ye20b,NULL,New,,NULL
Yebra09,NULL,PLOSMED2015,64 pol sequences in GB contains 60 RTs from 59 pts; Immigrants from SSA;,NULL
Yebra10,NULL,PLOSMED2015,Only 223 sequences in GB;,NULL
Yerly01,NULL,EX,Previously excluded; Not a representative study,NULL
Yerly04,NULL,PLOSMED2015,phylogenetically closely related IVDUs,NULL
Yin20,NULL,New,,NULL
Youngpairoj12,NULL,PLOSMED2015,,NULL
Yousef16,NULL,JIntAIDSSoc2020,,NULL
Yu09,NULL,PLOSMED2015,Study of polymorphism,NULL
Yu20,NULL,New,,NULL
Yuan18,NULL,JIntAIDSSoc2020,,NULL
Zain17,NULL,JIntAIDSSoc2020,,NULL
Zaki20,NULL,New,,NULL
Zarandia06,NULL,PLOSMED2015,A Former Soviet Union,NULL
Zeh05,NULL,EX,<25 RTs (0 RTs),NULL
Zeh16,NULL,JIntAIDSSoc2020,,NULL
Zeng11,NULL,PLOSMED2015,,NULL
Zeng12,NULL,PLOSMED2015,222 of 349 Accessions contain RT.,NULL
Zeng13,NULL,PLOSMED2015,,NULL
Zeng17,NULL,New,,NULL
Zeng20,NULL,New,,NULL
Zhang10,NULL,PLOSMED2015,WHO HIVDR-TS Survey,NULL
Zhang15,NULL,JIntAIDSSoc2020,,NULL
Zhang15b,NULL,JIntAIDSSoc2020,,NULL
Zhang17,NULL,EX,Rx not stated,NULL
Zhang19,NULL,EX,<25 PTs,NULL
Zhao14,NULL,JIntAIDSSoc2020,,NULL
Zhao16,NULL,JIntAIDSSoc2020,,NULL
Zhao20,NULL,New,,NULL
Zheng13,NULL,JIntAIDSSoc2020,Sequences available since 2013,NULL
Zhong03,NULL,EX,<25 RTs (0 RTs),NULL
Zhou08,NULL,EX,Rx not stated,NULL
Zhou14,NULL,JIntAIDSSoc2020,,NULL
Zhu95,NULL,EX,<25 Pts,NULL
Zuckerman19,NULL,JIntAIDSSoc2020,,NULL
daSilveira12,NULL,PLOSMED2015,Mato Grosso do Sul State (central western Brazil),NULL
deCastro14,NULL,JIntAIDSSoc2020,,NULL
deCoul00,NULL,EX,<25 RTs (14 RTs),NULL
deMedeiros11,NULL,PLOSMED2015,,NULL
deParga05,NULL,PLOSMED2015,A Former Soviet Union; Mainly subtype A; 7 patients with L23I alone; Phylogenetically closely related sequences,Set_Continent_To: Europe
deSaFilho02,NULL,EX,Excluded Previously (Unpublished),NULL
deSaFilho06,NULL,EX,<25 RTs (10 RTs),NULL
deSaFilho09,NULL,PLOSMED2015,Only 30 sequences are available in GB.,NULL
deSilva11,NULL,EX,<25 RTs (3 RTs),NULL
vanDerHoek07,NULL,EX,<25 RTs (4 RTs),NULL
vanHal09,NULL,EX,<25 RTs,NULL
vanHarmelen01,NULL,EX,<25 RTs (4 RTs),NULL
vanZyl17,NULL,JIntAIDSSoc2020,,NULL